Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism
- PMID: 782834
- DOI: 10.2165/00003495-197611050-00001
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism
Similar articles
-
[Somatosensory evoked potentials in patients with parkinsonism during L-dopa decarboxylase inhibitor treatment].Neurol Neurochir Pol. 1977 Jan-Feb;11(1):73-80. Neurol Neurochir Pol. 1977. PMID: 840365 Polish. No abstract available.
-
Comparison of levodopa with carbidopa or benserazide in parkinsonism.Lancet. 1976 Aug 21;2(7982):381-4. doi: 10.1016/s0140-6736(76)92403-x. Lancet. 1976. PMID: 73849 Clinical Trial.
-
[Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].Rinsho Shinkeigaku. 1976 Jul 1;16(7):511-9. Rinsho Shinkeigaku. 1976. PMID: 986921 Japanese. No abstract available.
-
Levodopa treatment of Parkinson's syndrome: past and future.Adv Neurol. 1990;53:469-73. Adv Neurol. 1990. PMID: 2239486 Review. No abstract available.
-
Levodopa.Ann Intern Med. 1975 Nov;83(5):677-82. doi: 10.7326/0003-4819-83-5-677. Ann Intern Med. 1975. PMID: 128308 Review.
Cited by
-
The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.Br J Clin Pharmacol. 1989 Jul;28(1):61-9. doi: 10.1111/j.1365-2125.1989.tb03506.x. Br J Clin Pharmacol. 1989. PMID: 2775615 Free PMC article. Clinical Trial.
-
The influence of levodopa on gastric emptying in man.Br J Clin Pharmacol. 1990 Jan;29(1):47-53. doi: 10.1111/j.1365-2125.1990.tb03601.x. Br J Clin Pharmacol. 1990. PMID: 2404503 Free PMC article.
-
The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.Br J Pharmacol. 1990 Aug;100(4):743-8. doi: 10.1111/j.1476-5381.1990.tb14085.x. Br J Pharmacol. 1990. PMID: 2119841 Free PMC article.
-
A risk-benefit assessment of drugs used in the management of Parkinson's disease.Drug Saf. 1994 Aug;11(2):94-103. doi: 10.2165/00002018-199411020-00004. Drug Saf. 1994. PMID: 7946003 Review.
-
Intestinal absorption of levodopa in man.Eur J Clin Pharmacol. 1983;25(1):69-72. doi: 10.1007/BF00544017. Eur J Clin Pharmacol. 1983. PMID: 6617727
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources